Ulcerlmin en es it fr

Ulcerlmin Brand names, Ulcerlmin Analogs

Ulcerlmin Brand Names Mixture

  • No information avaliable

Ulcerlmin Chemical_Formula


Ulcerlmin RX_link


Ulcerlmin fda sheet

Ulcerlmin FDA

Ulcerlmin msds (material safety sheet)

Ulcerlmin MSDS

Ulcerlmin Synthesis Reference

No information avaliable

Ulcerlmin Molecular Weight

258.23 g/mol

Ulcerlmin Melting Point

270 oC

Ulcerlmin H2O Solubility

545 mg/L

Ulcerlmin State


Ulcerlmin LogP


Ulcerlmin Dosage Forms

Tablets for oral administration (50 mg); Capsules for oral administration (50 mg, 100 mg and 200 mg)

Ulcerlmin Indication

For the acute treatment of the cutaneous manifestations of moderate to severe erythema nodosum leprosum (ENL). Also for use as maintenance therapy for prevention and suppression of the cutaneous manifestations of ENL recurrence.

Ulcerlmin Pharmacology

Thalidomide is an immunomodulatory agent with a spectrum of activity that is not fully characterized. Thalidomide is racemic — it contains both left and right handed isomers in equal amounts: one enantiomer is effective against morning sickness, and the other is teratogenic. The enantiomers are converted to each other in vivo. That is, if a human is given D-thalidomide or L-thalidomide, both isomers can be found in the serum. Hence, administering only one enantiomer will not prevent the teratogenic effect in humans.

Ulcerlmin Absorption

The absolute bioavailability has not yet been characterized in human subjects due to its poor aqueous solubility. In studies of both healthy volunteers and subjects with Hansen’s disease, the mean time to peak plasma concentrations (Tmax) ranged from 2.9 to 5.7 hours indicating that thalidomide is slowly absorbed from the gastrointestinal tract.

Ulcerlmin side effects and Toxicity

The R-configuration and the S-configuration are more toxic individually than the racemic mixture. The LD50 could not be established in mice for racemic thalidomide, whereas LD50 values for the R and S configurations are reported to be 0.4 to 0.7 g/kg and 0.5 to 1.5 g/kg, respectively.

Ulcerlmin Patient Information

Ulcerlmin Organisms Affected

Humans and other mammals